AbbVie Inc. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
AbbVie Inc. (ABBV) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$101.00 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-08.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2020-05-08
- AbbVie Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2020-03-31 was -$101.00M.
- AbbVie Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2019-12-31 was -$1.07B, a 1451.90% decline year-over-year.
- AbbVie Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2019-09-30 was -$37.00M, a 146.25% decline year-over-year.
- AbbVie Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2019-06-30 was $25.00M.
- AbbVie Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2019 was -$1.12B, a 551.82% decline from fiscal 2018.
- AbbVie Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2018 was $247.00M.
- AbbVie Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2017 was -$141.00M.
- AbbVie Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2016 was -$25.00M.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2020-03-31 | -$101.00M 10-Q · filed 2020-05-08 | -$1.17B derived: sum of 2 quarters · filed 2020-05-08 | -$1.21B derived: sum of 3 quarters · filed 2020-05-08 | -$1.18B derived: sum of 4 quarters · filed 2020-05-08 |
| 2019-12-31 | -$1.07B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | -$1.10B derived: sum of 2 quarters · filed 2020-02-21 | -$1.08B derived: sum of 3 quarters · filed 2020-02-21 | -$1.12B 10-K · filed 2020-02-21 |
| 2019-09-30 | -$37.00M 10-Q · filed 2019-11-06 | -$12.00M derived: sum of 2 quarters · filed 2019-11-06 | -$48.00M 10-Q · filed 2019-11-06 | $31.00M derived: sum of 4 quarters · filed 2020-05-08 |
| 2019-06-30 | $25.00M 10-Q · filed 2019-08-05 | -$11.00M 10-Q · filed 2019-08-05 | $68.00M derived: sum of 3 quarters · filed 2020-05-08 | $148.00M derived: sum of 4 quarters · filed 2020-05-08 |
| 2019-03-31 | -$36.00M 10-Q · filed 2020-05-08 | $43.00M derived: sum of 2 quarters · filed 2020-05-08 | $123.00M derived: sum of 3 quarters · filed 2020-05-08 | $114.00M derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | $79.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $159.00M derived: sum of 2 quarters · filed 2020-02-21 | $150.00M derived: sum of 3 quarters · filed 2020-02-21 | $247.00M 10-K · filed 2020-02-21 |
| 2018-09-30 | $80.00M 10-Q · filed 2019-11-06 | $71.00M derived: sum of 2 quarters · filed 2019-11-06 | $168.00M 10-Q · filed 2019-11-06 | $54.00M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-06-30 | -$9.00M 10-Q · filed 2019-08-05 | $88.00M 10-Q · filed 2019-08-05 | -$26.00M derived: sum of 3 quarters · filed 2020-02-21 | -$91.00M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-03-31 | $97.00M 10-Q · filed 2019-05-03 | -$17.00M derived: sum of 2 quarters · filed 2020-02-21 | -$82.00M derived: sum of 3 quarters · filed 2020-02-21 | -$88.00M derived: sum of 4 quarters · filed 2020-02-21 |
| 2017-12-31 | -$114.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | -$179.00M derived: sum of 2 quarters · filed 2020-02-21 | -$185.00M derived: sum of 3 quarters · filed 2020-02-21 | -$141.00M 10-K · filed 2020-02-21 |
| 2017-09-30 | -$65.00M 10-Q · filed 2018-11-07 | -$71.00M derived: sum of 2 quarters · filed 2018-11-07 | -$27.00M 10-Q · filed 2018-11-07 | -$273.00M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | -$6.00M 10-Q · filed 2018-08-07 | $38.00M 10-Q · filed 2018-08-07 | -$208.00M derived: sum of 3 quarters · filed 2019-02-27 | -$158.00M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $44.00M 10-Q · filed 2018-05-04 | -$202.00M derived: sum of 2 quarters · filed 2019-02-27 | -$152.00M derived: sum of 3 quarters · filed 2019-02-27 | -$119.00M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | -$246.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$196.00M derived: sum of 2 quarters · filed 2019-02-27 | -$163.00M derived: sum of 3 quarters · filed 2019-02-27 | -$25.00M 10-K · filed 2019-02-27 |
| 2016-09-30 | $50.00M 10-Q · filed 2017-11-07 | $83.00M derived: sum of 2 quarters · filed 2017-11-07 | $221.00M 10-Q · filed 2017-11-07 | $159.00M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-06-30 | $33.00M 10-Q · filed 2017-08-07 | $171.00M 10-Q · filed 2017-08-07 | $109.00M derived: sum of 3 quarters · filed 2018-02-16 | -$16.00M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-03-31 | $138.00M 10-Q · filed 2017-05-05 | $76.00M derived: sum of 2 quarters · filed 2018-02-16 | -$49.00M derived: sum of 3 quarters · filed 2018-02-16 | $44.00M derived: sum of 4 quarters · filed 2018-02-16 |
| 2015-12-31 | -$62.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | -$187.00M derived: sum of 2 quarters · filed 2018-02-16 | -$94.00M derived: sum of 3 quarters · filed 2018-02-16 | -$530.00M 10-K · filed 2018-02-16 |
| 2015-09-30 | -$125.00M 10-Q · filed 2016-11-07 | -$32.00M derived: sum of 2 quarters · filed 2016-11-07 | -$468.00M 10-Q · filed 2016-11-07 | -$1.59B derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-06-30 | $93.00M 10-Q · filed 2016-08-05 | -$343.00M 10-Q · filed 2016-08-05 | -$1.46B derived: sum of 3 quarters · filed 2017-02-17 | -$1.95B derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-03-31 | -$436.00M 10-Q · filed 2016-05-06 | -$1.55B derived: sum of 2 quarters · filed 2017-02-17 | -$2.05B derived: sum of 3 quarters · filed 2017-02-17 | -$2.04B derived: sum of 4 quarters · filed 2017-02-17 |
| 2014-12-31 | -$1.12B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | -$1.61B derived: sum of 2 quarters · filed 2017-02-17 | -$1.60B derived: sum of 3 quarters · filed 2017-02-17 | -$1.59B 10-K · filed 2017-02-17 |
| 2014-09-30 | -$493.00M 10-Q · filed 2015-11-06 | -$487.00M derived: sum of 2 quarters · filed 2015-11-06 | -$471.00M 10-Q · filed 2015-11-06 | $48.00M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-06-30 | $6.00M 10-Q · filed 2015-08-07 | $22.00M 10-Q · filed 2015-08-07 | $541.00M derived: sum of 3 quarters · filed 2016-02-19 | $729.00M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-03-31 | $16.00M 10-Q · filed 2015-05-08 | $535.00M derived: sum of 2 quarters · filed 2016-02-19 | $723.00M derived: sum of 3 quarters · filed 2016-02-19 | $791.00M derived: sum of 4 quarters · filed 2016-02-19 |
| 2013-12-31 | $519.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $707.00M derived: sum of 2 quarters · filed 2016-02-19 | $775.00M derived: sum of 3 quarters · filed 2016-02-19 | $570.00M 10-K · filed 2016-02-19 |
| 2013-09-30 | $188.00M 10-Q · filed 2014-11-07 | $256.00M derived: sum of 2 quarters · filed 2014-11-07 | $51.00M 10-Q · filed 2014-11-07 | $41.00M derived: sum of 4 quarters · filed 2015-02-20 |
| 2013-06-30 | $68.00M 10-Q · filed 2014-08-07 | -$137.00M 10-Q · filed 2014-08-07 | -$147.00M derived: sum of 3 quarters · filed 2015-02-20 | $134.00M derived: sum of 4 quarters · filed 2015-02-20 |
| 2013-03-31 | -$205.00M 10-Q · filed 2014-05-09 | -$215.00M derived: sum of 2 quarters · filed 2015-02-20 | $66.00M derived: sum of 3 quarters · filed 2015-02-20 | -$454.00M derived: sum of 4 quarters · filed 2015-02-20 |
| 2012-12-31 | -$10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-20 | $271.00M derived: sum of 2 quarters · filed 2015-02-20 | -$249.00M derived: sum of 3 quarters · filed 2015-02-20 | -$29.00M 10-K · filed 2015-02-20 |
| 2012-09-30 | $281.00M 10-Q · filed 2013-11-12 | -$239.00M derived: sum of 2 quarters · filed 2013-11-12 | -$19.00M 10-Q · filed 2013-11-12 | |
| 2012-06-30 | -$520.00M 10-Q · filed 2013-08-09 | -$300.00M 10-Q · filed 2013-08-09 | ||
| 2012-03-31 | $220.00M 10-Q · filed 2013-05-08 | |||
| 2011-12-31 | -$313.00M 10-K · filed 2014-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |